Resources

Any of the resources listed on this site may contain viewpoints and opinions of the various authors, organisations, media outlets, and other bodies and are not necessarily reflective of the viewpoints of KATA. We recommend that when accessing content to use your discretion and discernment.

Author(s)	Title	Date	Journal
Mathai et al.	Toward Synergies of Ketamine and Psychotherapy.	2022	Frontiers in Psychology
Gagne et al.	Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women.	2022	Frontiers in Psychiatry
Passie at al.	Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers.	2021	European Neuropsychopharmacology
Feder et al.	A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.	2021	The American Journal of Psychiatry
Wolfson et al.	The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of ketamine and metabolites.	2021
Mollaahmetoglu et al.	“This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders.	2021	Frontiers in Psychiatry
Song and Zhu	Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review.	2021	Frontiers in Pharmacology
Bonnett et al.	Intramuscular Ketamine to Treat Major Depressive Disorder: A Case Series of Forty Patients.	2021	Sci Forschen
McIntrye et al.	Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.	2021	American Journal of Psychiatry
Wajs et al.	Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2).	2020	The Journal of Clinical Psychiatry
Ochs-Ross et al.	Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.	2020	The American Journal of Geriatric Psychiatry
Mathai et al.	The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.	2020	Journal of Affective Disorders
Kryst et al.	Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: A meta-analysis of randomized clinical trials.	2020	Pharmacological Reports
Grabski et al.	Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.	2020	Behavioural Brain Research
Feifel et al.	Safety of Repeated Administration of Parenteral Ketamine for Depression.	2020	Pharmaceuticals
Fava et al.	Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).	2020	Molecular Psychiatry
Dames	Ketamine-assisted Psychotherapy within a Roots to Thrive Community of Practice: Building a Strong Foundation.	2020
Ballard and Zarate	The role of dissociation in ketamine’s antidepressant effects.	2020	Nature Communication
Nuñez et al.	An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis.	2020	Psychopharmacology Bulletin
Ross et al.	High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans.	2019	Annals of Clinical Psychiatry
Ionescu et al.	Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.	2019	Journal of Affective Disorders
Dore et al.	Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy.	2019	Journal of Psychoactive Drugs
Riva-Posse et al.	Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions.	2018	Journal of Affective Disorders
Short et al.	Side-effects associated with ketamine use in depression: a systematic review.	2018	Lancet Psychiatry
Grunebaum et al.	Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.	2018	The American Journal of Psychiatry
Glue et al.	Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.	2017	International Journal of Neuropsychopharmacology
Xu et al.	Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.	2016	International Journal of Neuropsychopharmacology
Bellolio et al.	Incidence of adverse events in adults undergoing procedural sedation in the Emergency Department: A systematic review and meta‐analysis.	2016	Academic Emergency Medicine
Lapidus et al.	A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder.	2014	Biological Psychiatry
Feder et al.	Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.	2014	Jama Psychiatry
Steven et al.	Ketamine and Intracranial Pressure: No Contraindication Except Hydrocephalus.	2014	Annals of Emergency Medicine

Organisation		Details
Roots to Thrive	Nanaimo	Experiential training with a blend of virtual and in-person sessions for preparing and supporting people in non ordinary states, and integration processes for self and others.
Breakthrough Therapies	Toronto	Three levels of online and in person training geared to inform about the principles and practical procedures with a focus on Ketamine Assisted Psychotherapy (KAP).
Numinus	CAN	Designed to develop a core ketamine assisted therapy skill set through case-based learning, experiential training, and practicum placements with a clear path to practice.
The Ketamine Training Center	US	In person residential Ketamine Assisted Psychotherapy training for practitioners with experiential component.
Polaris Insight Center	US	Didactic, experiential, and residential training in Ketamine Assisted Therapy – experiential component offered, CE available.
Polaris and Rainfall	US	Expected to be a 1-2 year certificate training for licensed clinicians.
PRATI	US	Immersive KAP training combining didactic and optional experiential components in a retreat-style setting.
The Sage Institute	US	Combined lecture and experiential learning for licensed clinicians with an experiential component.
California Institute of Integral Studies (CIIS)	US	The Psychedelic-Assisted Therapies and Research Certificate Program.
Fluence	US	An introduction to the varied approaches ketamine is used in mental health, including preparation, integration, assisted psychotherapy.
Psychedelic Support	US	Ketamine: Therapeutic effects, clinical research & neural mechanisms: 5 hours of learning content in eLearning modules.
Psychedelic Support	US	Advanced Topics in Ketamine and Psychedelic Assisted Therapy: The continuation of the 5 module program.
Psychedelic Support	US	The Embrace of Space: Music for Ketamine-Assisted Psychotherapy Sessions Live/Online.

The KRIYA Conference – Intends to bring together the most rigorous Science and an appreciation of Spirit in the study of psychospiritual medicines such as ketamine.

Ketamine and Related Compounds International Virtual Conference – Includes recordings hosted on Youtube from their 2021 virtual conference.

Research to Reality – First Global Summit of its Kind on Psychedelic-Assisted Therapies and Medicine, bringing policymakers, researchers, and clinicians together.

Ketamine Psychotherapy Associates – Advanced Training KAP Conference

January 10, 2022

Clinical trial finds ketamine-assisted therapy helps treat alcoholism

September 2, 2021

Ketamine Treatment Guide for Mental Health

March 19, 2021

op-ed: Mind the ketamine education gap

March 19, 2021

Ketamine for Depression: The Highs and the Lows

March 13, 2021

"The ketamine blew my mind": can psychedelics cure addiction and depression?

February 24, 2021

We Look at a Ketamine Assisted Therapy Study out of Vancouver Island University

January 16, 2021

Ketamine Clinicians Publish Ethical Guidelines to Raise Treatment Standards

The Ketamine Research Foundation – Dedicated to research, education and training.

KRIYA – Is devoted to understanding the therapeutic properties of ketamine.

Ketamine & Related Compounds International Journal Club – A series of free, short, 30-minute webinars held every two weeks. Held on 2nd and 4th Tuesdays at 12:30pm EST (usually 9:30am Pacific, 5:30pm GMT, 11:00pm Indian Standard).

Roots to Thrive – A non-profit healthcare practice based in BC offering multi-week, group therapy programs that use a community of practice model combined with ketamine assisted therapy.

Ethical guidelines – KRIYA ethical guidelines for ketamine clinicians, by Raquel Bennett

North Star Ethics Pledge – The purpose of the pledge is to begin the task of creating shared values for the emerging psychedelic field. The pledge can be used as a tool for each of us to set and name our intention for this work.